研究成果

2023年

  1. Hoshino K, Nakazawa S, Yokobori T, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Araki K, Harimoto N, Tokunaga F, Shirabe K. RNF31 promotes proliferation and invasion of hepatocellular carcinoma via nuclear factor kappaB activation. Sci. Rep. 14(1), 346, (2023).
  2. Yanagawa H, Hara Y, Ando F, Suzuki S, Fujiki T, Oikawa D, Yui N, Mandai S, Mori Y, Susa K, Mori T, Sohara E, Tokunaga F, Uchida S. LRBA signalosomes activate vasopressin-induced AQP2 trafficking at recycling endosomes. J. Physiol. 601(23), 5437-5451, (2023).
  3. 徳永文稔;v-relがん遺伝子からNF-κB転写因子への研究展開(2023)生体の科学 744 359-364
  4. Fukushi M, Ohsawa R, Okinaka Y, Oikawa D, Kiyono T, Moriwaki M, Irie T, Oda K, Kamei Y, Tokunaga F, Sotomaru Y, Maruyama H, Kawakami H, Sakaguchi T. Optineurin deficiency impairs autophagy to cause interferon beta overproduction and increased survival of mice following viral infection PLoS One 18(6):e0287545, (2023).
  5. Oikawa D, Shimizu K, Tokunaga F. Pleiotropic roles of a KEAP1-associated deubiquitinase, OTUD1. Antioxidants 12(2), 350, (2023).
  6. Sato Y, Terawaki S, Oikawa D, Shimizu K, Okina Y, Ito H, Tokunaga F. Involvement of heterologous ubiquitination including linear ubiquitination in Alzheimer's disease and amyotrophic lateral sclerosis. Front. Mol. Biosci. 10, 1089213, (2023).

2022年

  1. Saito R, Tada Y, Oikawa D, Sato Y, Seto M, Satoh A, Kume K, Ueki N, Nakashima M, Hayashi S, Toyoshima Y, Tokunaga F, Kawakami H, Kakita A. Spinocerebellar ataxia type 17-digenic TBP/STUB1 disease: neuropathologic features of an autopsied patient. Acta. Neuropathol. Commun. 10(1), 177, (2022).
  2. Nakazawa S, Mamiya R, Kawabata-Iwakawa R, Oikawa D, Kaira K, Tokunaga F, Nobusawa S, Sato Y, Sasaki A, Yajima T, Shirabe K. Identification and molecular analysis of RNF31 Q622H germline polymorphism. Oncol. Lett, 24(5),394, (2022).
  3. Oikawa D, Gi M, Kosako H, Shimizu K, Takahashi H, Shiota M, Hosomi S, Komakura K, Wanibuchi H, Tsuruta D, Sawasaki T, Tokunaga F. OTUD1 deubiquitinase regulates NF-κB- and KEAP1-mediated inflammatory responses and reactive oxygen species-associated cell death pathways. Cell Death Dis., 13,694, (2022).
  4. Zhang Q, Terawaki S, Oikawa D, Okina Y, Usuki Y, Ito H, Tokunaga F. Suppression of linear ubiquitination ameliorates cytoplasmic aggregation of truncated TDP-43. Cells, 11, 2398, (2022).
  5. Hara Y, Ando F, Oikawa D, Ichimura K, Yanagawa H, Sakamaki Y, Nanamatsu A, Fujiki T, Mori S, Suzuki S, Yui N, Mandai S, Susa K, Mori T, Sohara E, Rai T, Takahashi M, Sasaki S, Kagechika, H, Tokunaga F, Uchida S. LRBA is essential for urinary concentration and body water homeostasis. Proc. Natl. Acad. Sci. USA, 119, e2202125119, (2022).
  6. Yoshizato K, Taira T, Sato-Matsubara M, Sekiguchi S, Yabunaka Y, Kira Y, Ohashi T, Daikoku A, Ofusa K, Kadono C, Oikawa D, Matsubara T, Nakagama Y, Kido Y, Tokunaga F, Ikeda K, Kaneko A, Kawada N. Cloaking the ACE2 receptor with salivary cationic proteins inhibits SARS-CoV-2 entry. J. Biochem. 172(4), 205-216, (2022).
  7. Hoang DV, Thuy LTT, Hai H, Hieu VN, Kimura K, Oikawa D, Ikura Y, Dat NQ, Hoang TH, Sato-Matsubara M, Dong MP, Hanh NV, Uchida-Kobayashi S, Tokunaga F, Kubo S, Ohtani N, Yoshizato K, Kawada N. Cytoglobin attenuates pancreatic cancer growth via scavenging reactive oxygen species. Oncogenesis, 11, 23, (2022)
  8. Tokunaga F, Ikeda F. Linear ubiquitination in immune and neurodegenerative diseases, and beyond. Biochem. Soc. Trans., 50(2), 799-811, (2022)
  9. Hieu VN, Thuy LTT, Hai H, Dat NQ, Hoang DV, Hanh NV, Phuong DM, Hoang TH, Sawai H, Shiro Y, Sato-Matsubara M, Oikawa D, Tokunaga F, Yoshizato K, Kawada N. Capacity of extracellular globins to reduce liver fibrosis via scavenging reactive oxygen species and promoting MMP-1 secretion. Redox Biol., 52, 102286, (2022)

2021年

  1. Kuriyama Y, Shimizu A, Kanai S, Oikawa D, Motegi SI, Tokunaga F, Ishikawa O. Coordination of retrotransposons and type I interferon with distinct interferon pathways in dermatomyositis, systemic lupus erythematosus and autoimmune blistering disease. Sci. Rep., 11, 23146, (2021)
  2. Iwasaki N, Terawaki S, Shimizu K, Oikawa D, Sakamoto H, Sunami K, Tokunaga F. Th2 cell-derived histamine is involved in nasal Th2 infiltration in mice. Inflamm. Res., 70, 539-541, (2021)
  3. Iwasaki N, Terawaki S, Shimizu K, Oikawa D, Sakamoto H, Sunami K, Tokunaga F. Th2 cells and macrophages cooperatively induce allergic inflammation through histamine signaling. PLoS One, 16, e0248158, (2021)
  4. Shimizu K, Gi M, Suzuki S, North BJ, Watahiki A, Fukumoto S, Asara JM, Tokunaga F, Wei W, Inuzuka H. Interplay between protein acetylation and ubiquitination controls MCL1 protein stability. Cell Rep., 37(6), 109988, (2021)
  5. Miyashita H+, Oikawa D+(+ equally contributed), Terawaki S, Kabata D, Shintani A, Tokunaga F. Crosstalk between NDP52 and LUBAC in innate immune responses, cell death, and xenophagy. Front. Immunol., 12, 635475, (2021)
  6. Dat NQ, Thuy LTT, Hieu VN, Hai H, Hoang DV, Thi Thanh Hai N, Thuy TTV, Komiya T, Rombouts K, Dong MP, Hanh NV, Hoang TH, Sato-Matsubara M, Daikoku A, Kadono C, Oikawa D, Yoshizato K, Tokunaga F, Pinzani M, Kawada N. 6His-tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species. Hepatology, 73(6), 2527-2545, (2021)
  7. Kuriyama Y, Shimizu A, Kanai S, Oikawa D, Tokunaga F, Tsukagoshi H, Ishikawa O. The synchronized gene expression of retrotransposons and type I interferon in dermatomyositis. J. Am. Acad. Dermatol., 84, 1103-1105, (2021)
  8. Nakabayashi O, Takahashi H, Moriwaki K, Komazawa-Sakon S, Ohtake F, Murai S, Tsuchiya Y, Koyahara Y, Saeki Y, Yoshida Y, Yamazaki S, Tokunaga F, Sawasaki T, Nakano H. MIND bomb 2 prevents RIPK1 kinase activity-dependent and -independent apoptosis through ubiquitylation of cFLIPL. Commun. Biol., 4(1), 80, (2021)
  9. 徳永文稔;cyclic GMP-AMP synthase (cGAS) (2021) アレルギー 70巻9号 1239-1240
  10. 徳永文稔;直鎖状ユビキチン鎖による炎症制御 (2021) 炎症と免疫 29巻3号 201-208

2020年

  1. Oikawa D, Hatanaka N, Suzuki T, Tokunaga F. Cellular and mathematical analyses of LUBAC involvement in T cell receptor-mediated NF-κB activation pathway. Front. Immunol.,11, 601926, (2020)
  2. Okina Y, Matsubara-Sato M, Matsubara T, Daikoku A, Longato L, Rombouts K, Thuy Le TT, Ichikawa H, Minamiyama Y, Kadota M, Fujii H, Enomoto M, Ikeda K, Yoshizato K, Pinzani M, Kawada N. TGF-β1-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis. J. Hepatol., 73, 882-895, (2020)
  3. Takahashi H, Yamanaka S, Kuwada S, Higaki K, Kido K, Sato Y, Fukai S, Tokunaga F, Sawasaki T. A Human DUB Protein Array for Clarification of Linkage Specificity of Polyubiquitin Chain and Application to Evaluation of Its Inhibitors. Biomedicines 8, 152, (2020)
  4. Kuriyama Y, Shimizu A, Kanai S, Oikawa D, Tokunaga F, Tsukagoshi H, Ishikawa O. The synchronized gene expression of retrotransposons and type I interferon in dermatomyositis. J. Am. Acad. Dermatol. S0190-9622 (20)30916-6, (2020)
  5. Oikawa D, Sato Y, Ito H, Tokunaga F. Linear ubiquitin code: Its writer, erasers, decoders, inhibitors, and implications in disorders. Int. J. Mol. Sci. 21, 3381, (2020)
  6. Oikawa D, Sato Y, Ohtake F, Komakura K, Hanada K, Sugawara K, Terawaki S, Mizukami Y, Phuong HT, Iio K, Obika S, Fukushi M, Irie T, Tsuruta D, Sakamoto S, Tanaka K, Saeki Y, Fukai S, Tokunaga F. Molecular bases for HOIPINs-mediated inhibition of LUBAC and innate immune responses. Commun. Biol. 3, 163, (2020)
  7. Nakayama Y, Tsuji K, Ayaki T, Mori M, Tokunaga F, Ito H. Linear polyubiquitin chain modification of TDP-43-Positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 79, 256-265, (2020)
  8. Yamanaka S, Sato Y, Oikawa D, Goto E, Fukai S, Tokunaga F., Takahashi H., Sawasaki T. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling. Biochem Biophys Res Commun. 524, 1-7, (2020)
  9. 及川大輔、伊藤秀文、徳永文稔;直鎖状ユビキチン鎖の神経変性疾患への関与とLUBAC阻害剤の開発、生化学92, 28-34, (2020)
  10. 高橋宏隆、山中聡士、徳永文稔、澤崎達也;ヒト脱ユビキチン化酵素タンパク質アレイの開発とその応用例、生化学92, 64-74, (2020)
  11. 徳永文稔;創薬を見据えた直鎖状ユビキチン鎖生成酵素(LUBAC)阻害剤開発、ファルマシア 56, 26-30, (2020)

2019

  1. Uematsu A, Kido K, Takahashi H, Takahashi C, Yanagihara Y, Saeki N, Yoshida S, Maekawa M, Honda M, Kai T, Shimizu K, Higashiyama S, Imai Y, Tokunaga F, Sawasaki T. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD. J. Biol. Chem. 294, 14135-14138, (2019)
  2. Nakayama Y, Sakamoto S, Tsuji K, Ayaki T, Tokunaga F, Ito H. Identification of linear polyubiquitin chain immunoreactivity in tau pathology of Alzheimer's disease. Neurosci. Lett.703, 53-57, (2019)
  3. Katsuya K, Oikawa D, Iio K, Obika S, Hori Y, Urashima T, Ayukawa K, Tokunaga F. Small-molecule inhibitors of linear ubiquitin chain assembly complex (LUBAC), HOIPINs, suppress NF-κB signaling. Biochem. Biophys. Res. Commun. 509(3), 700-706, (2019)
  4. 徳永文稔. LUBACを介した直鎖状ユビキチン鎖生成と細胞死 臨床免疫・アレルギー科71(2), 105-113 (2019)

2018

  1. Kato K, Nishimasu H, Oikawa D, Hirano S, Hirano H, Kasuya G, Ishitani R, Tokunaga F, Nureki O Structural insights into cGAMP degradation by Ecto-nucleotide pyrophosphatase phosphodiesterase 1. Nat Commun. 9(1):4424 (2018).
  2. Oikawa D, Shiota M, Goto E, Komakura K, Wanibuchi H, Tokunaga F. Generation of Rat Monoclonal Antibodies Against a Deubiquitinase, Ovarian Tumor Domain-Containing Protein 1.Monoclon Antib Immunodiagn Immunother. 37(4):180-184 (2018).
  3. Katsuya K, Hori Y, Oikawa D, Yamamoto T, Umetani K, Urashima T, Kinoshita T, Ayukawa K, Tokunaga F, Tamaru M. High-Throughput Screening for Linear Ubiquitin Chain Assembly Complex (LUBAC) Selective Inhibitors Using Homogenous Time-Resolved Fluorescence (HTRF)-Based Assay System. SLAS Discov. 2:2472555218793066 (2018).
  4. Oikawa D, Shiota M, Tokunaga F, Wanibuchi H. Generation of rat monoclonal antibodies specific for DZIP3. Monoclon. Antib. Immunodiagn. Immunother.37(3)157-157 (2018)
  5. Hattori M, Ishikawa O, Oikawa D, Amano H, Yasuda M, Kaira K, Ishida-Yamamoto A, Nakano H, Sawamura D, Terawaki SI, Wakamatsu K, Tokunaga F, Shimizu A. In-frame Val216-Ser217 deletion of KIT in mild piebaldism causes aberrant secretion and SCF response.J. Dermatol. Sci. 91(1) 35-42 (2018)
  6. Kuriyama Y, Hattori M, Mitsui T, Nakano H, Oikawa D, Tokunaga F, Ishikawa O, Shimizu A. Generalized verrucosis caused by various human papillomaviruses in a patient with GATA2 deficiency. J. Dermatol. 45(5), e108-e109 (2018)
  7. 徳永文稔. 脱ユビキチン化酵素(DUB)と疾患 医学のあゆみ267(13),1096-1104 (2018)

2017

  1. Shibata Y, Tokunaga F, Goto E, Komatsu G, Gohda J, Saeki Y, Tanaka K, Takahashi H, Sawasaki T, Inoue S, Oshiumi H, Seya T, Nakano H, Tanaka Y, Iwai K, and Inoue JI. HTLV-1 Tax induces formation of the active macromolecular IKK complex by generating Lys63- and Met1-linked hybrid polyubiquitin chains. PLoS Pathogens. 13, e100162 (2017)
  2. Hattori M, Shimizu A, Oikawa D, Kamei K, Kaira K, Ishida-Yamamoto A, Nakano H, Sawamura D, Tokunaga F, Ishikawa O. Endoplasmic reticulum stress in the pathogenesis of pretibial dystrophic epidermolysis bullosa. Br. J. Dermatol. 177(4), e92-e93 (2017)
  3. Yamamotoya T, Nakatsu Y, Matsunaga Y, Fukushima T, Yamazaki H, Kaneko S, Fujishiro M, Kikuchi T, Kushiyama A, Tokunaga F, Asano T, Sakoda H. Reduced SHARPIN and LUBAC formation may contribute to CCl₄- or acetaminophen-induced liver cirrhosis in mice. Int. J. Mol. Sci. 18(2), 326 (2017)
  4. Goto E and Tokunaga F. Decreased linear ubiquitination of NEMO and FADD on apoptosis with caspase-mediated cleavage of HOIP. Biochem. Biophys. Res. Commun. 485(1), 152-159 (2017)

2016

  1. Omura H, Oikawa D, Nakane T, Kato M, Ishii R, Ishitani R, Tokunaga F, and Nureki O: Structural and functional analysis of DDX41: a bispecific immune receptor for DNA and cyclic dinucleotide. Sci. Rep. 6, 34756 (2016).
  2. Nakazawa S, Oikawa D, Ishi R, Ayaki T, Takahashi H, Takeda H, Ishitani R, Kamei K, Takeyoshi I, Kawakami H, Iwai K, Hatada I, Sawasaki T, Ito H, Nureki O, and Tokunaga F: Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis. (2016) Nat. Commun. 7, 12547.
  3. Saitoh Y, Hamano A, Mochida K, Kakeya A, Uno M, Tsuruyama E, Ichikawa H, Tokunaga F, Utsnomiya A, Watanabe T, and Yamaoka S: A20 targets caspase-8 and FADD to protect HTLV-I infected cells. (2016) Leukemia, 30, 716-727.

2015

  1. Kumanomidou T, Nishio K, Takagi K, Nakagawa T, Suzuki A, Yamane T, Tokunaga F, Iwai K, Murakami A, Yoshida Y, Tanaka K, and Mizushima T: The Structural Differences between a Glycoprotein Specific F-box Protein Fbs1 and its Homologous Protein FBG3. (2015) PLoS One, 10, e0140366.
  2. Matsunaga Y, Nakatsu Y, Fukushima T, Okubo H, Iwashita M, Sakoda H, Fujishiro M, Yamamotoya T, Kushiyama A, Takahashi S, Tsuchiya Y, Kamata H, Tokunaga F, Iwai K, and Asano T: 13. LUBAC formation is impaired in the livers of mice with MCD-dependent nonalcoholic steatohepatitis. (2015) Mediators Inflamm., 125380.
  3. Sato Y, Goto E, Shibata Y, Kubota Y, Yamagata A, Goto-Ito S, Kubota K, Inoue J, Takekawa M, Tokunaga F, and Fukai S: Structures of CYLD USP with Met1- or Lys63-linked diubiquitin reveal mechanisms for dual specificity. (2015) Nat. Struct. Mol. Biol., 22, 222-229.
  4. Kato M, Shimizu A, Yokoyama Y, Kaira K, Shimomura Y, Ishida-Yamamoto A, Kamei K, Tokunaga F, and Ishikawa O: A novel autosomal recessive mutation of DSG4 causes monilethrix through the ER stress response. (2015) Invest. Dermatol., 135, 1253-1260.
  5. Tokunaga F. Ubiquitination-mediated NF-kB regulation in inflammatory response. In: Protein modifications in pathogenic dysregulation of signaling. (Inoue J and Takekawa M, eds.) (2015) Springer International Publishing, Tokyo, 177-196.
  6. 徳永文稔. 直鎖状ユビキチン鎖による炎症制御.(2015) 臨床免疫・アレルギー科,63, 495-501.

2014

  1. 徳永文稔. 8番目のユビキチン鎖「直鎖状ユビキチン鎖」の機能と疾患へのかかわり–炎症、免疫応答に重要なNF-kB経路の新しい制御機構-.(2014) 化学と生物,52, 716-718.

2013

  1. Kazuki Kato, Ryohei Ishii, Eiji Goto, Ryuichiro Ishitani, Fuminori Tokunaga, and Osamu Nureki: Structural and functional analyses of DNA-sensing and immune activation by human cGAS. (2013) PLoS One, 8 (10), e76983.
  2. Naonobu Fujita, Eiji Morita, Takashi Itoh, Atsushi Tanaka, Megumi Nakaoka, Yuki Osada, Tetsuo Umemoto, Tatsuya Saitoh, Hitoshi Nakatogawa, Shouhei Kobayashi, Tokuko Hataguchi, Jun-Lin Guan, Kazuhiro Iwai, Fuminori Tokunaga, Kazunobu Saito, Koutaro Ishibashi, Shizuo Akira, Mitsunori Fukuda, Takeshi Noda, and Tamotsu Yoshimori: Recruitment of the autophagic machinery to endosomes during infection is mediated by ubiquitin. (2013) J. Cell Biol. 203 (1), 115-128.
  3. Fuminori Tokunaga: Linear ubiquitination-mediated NF-κB regulation and its related disorders. (2013) J. Biochem. 154 (4), 313-323.
  4. 櫻井宏明、徳永文稔;次世代シグナル伝達研究 -先駆的基礎解析と臨床・創薬への展開- (2013)生化学, 85(6), 403-404.
  5. 徳永文稔;直鎖状ユビキチン化を介したNF-κB制御機構と疾患 (2013)生化学, 85(6), 414-422.

2012

  1. Naguro I, Umeda T, Kobayashi Y, Maruyama J, Hattori K, Shimizu Y, Kataoka K, Kim-Mitsuyama S, Uchida S, Vandewalle A, Noguchi T, Nishitoh H, Matsuzawa A, Takeda K, Ichijo H: ASK3 responds to osmotic stress and regulates blood pressure by suppressing WNK1-SPAK/OSR1 signaling in the kidney.(2012) Nat Commun., 3, 1285.
  2. Fuminori Tokunaga*, Hiroshi Nishimasu*, Ryuichiro Ishitani, Eiji Goto, Takuya Noguchi, Kazuhiro Mio, Kiyoko Kamei, Averil Ma, Kazuhiro Iwai, and Osamu Nureki: Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation. (2012) EMBO J. 31 (19), 3856-3870, (*; equal contribution).
  3. Fuminori Tokunaga and Kazuhiro Iwai: Linear ubiquitination: A novel NF-kB regulatory mechanism for inflammatory and immune responses by the LUBAC ubiquitin ligase complex. (2012) Endocrine J., 59 (8), 641-652.
  4. Tobias Kensche*, Fuminori Tokunaga*, Fumiyo Ikeda, Eiji Goto, Kazuhiro Iwai, and Ivan Dikic: Analysis of NF-κB essential modulator (NEMO) binding to linear and lysine-linked ubiquitin chains and its role in the activation of NF-κB. (2012) J. Biol. Chem., 287 (28), 23626-23634, (*; equal contribution).
  5. Hirokazu Yagi, Kazuhiro Ishimoto, Takeshi Hiromoto, Hiroaki Fujita, Tsunehiro Mizushima, Yoshinori Uekusa, Maho Yagi-Utsumi, Eiji Kurimoto, Masanori Noda, Susumu Uchiyama, Fuminori Tokunaga, Kazuhiro Iwai, and Koichi Kato: Non-canonical UBA–UBL interaction mediates formation of linear ubiquitin chain assembly complex. (2012) EMBO Rep., 13 (5), 462-468.
  6. Fuminori Tokunaga and Kazuhiro Iwai: LUBAC, a novel ubiquitin ligase for linear ubiquitination, is crucial for inflammation and immune responses. (2012) Microbes Infect., 14 (7-8), 563-572.
  7. Yoshinori Uekusa, Syunsuke Miura, Hiroaki Sasakawa, Eiji Kurimoto, Eri Sakata, Serve Oliver, Hirokazu Yagi, Fuminori Tokunaga, Kazuhiro Iwai, and Koichi Kato; Backbone and side chain 1H, 13C, and 15N assignments of ubiquitin-like domain of human HOIL-1L, an essential component of linear ubiquitin chain assembly complex. Biomol. NMR Assign., 6 (2), 177-180 (2012)
  8. Masato Tomonaga, Nobuyuki Hashimoto, Fuminori Tokunaga, Megumi Onishi, Akira Myoui, Hideki Yoshikawa, and Kazuhiro Iwai; Activation of nuclear factor-kappa B by linear ubiquitin chain assembly complex contributes to lung metastasis of osteosarcoma cells. (2012) Int. J. Oncol. 40 (2), 409-417.
  9. Mizuho Kajikawa, Pai-Chi Li, Eiji Goto, Naoyuki Miyashita, Masami Aoki-Kawasumi, Mari Mito-Yoshida, Mika Ikegaya, Yuji Sugita, and Satoshi Ishido; The intramembrane region of Kaposi’s sarcoma-associated Herpesvirus modulator of immune recognition 2 contributes to B7-2 downregulation. (2012) J. Virol. 86 (9), 5286-5296.
  10. Hidetaka Tanno, Teppei Yamaguchi, Eiji Goto, Satoshi Ishido, and Masayuki Komada; The Ankrd 13 family of UIM-bearing proteins regulates EGF receptor endocytosis from the plasma membrane. (2012) Mol. Biol. Cell 23 (7), 1343-1353.
  11. 徳永文稔; NF-κB経路の多様なポリユビキチン鎖による制御と疾患 (2012) 実験医学増刊号,30(5), 716-723.

2011

  1. Fuminori Tokunaga, Tomoko Nakagawa, Masaki Nakahara, Yasushi Saeki, Masami Taniguchi, Shin-ichi Sakata, Keiji Tanaka, Hiroyasu Nakano, and Kazuhiro Iwai; Sharpin is a component of the NF-κB activating linear ubiquitin assembly complex. (2011) Nature, 471, 633-641.
    [http://www.ncbi.nlm.nih.gov/pubmed/21455180
  2. Fumiyo Ikeda, Yonathan Lissanu Deribe, Sigrid S. Skånland, Benjamin Stieglitz, Caroline Grabbe, Sjoerd van WijK, Mirita Franz-Wachtel, Panchali Goswami, Vanja Nagy, Janos Terzic, Fuminori Tokunaga, Ariadne Androulidaki, Tomoko Nakagawa, Manolis Pasparakis, Kazuhiro Iwai, John P. Sundberg, Liliana Schaefer, Boris Macek, Katrin Rittinger, and Ivan Dikic; SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. (2011) Nature, 471, 637-641.
    [http://www.ncbi.nlm.nih.gov/pubmed/21455181
  3. Kyung-Soo Inn, Michaela U. Gack, Fuminori Tokunaga, Mude Shi, Lai-Yee Wong, Kazuhiro Iwai, and Jae U. Jung; Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction. (2011) Mol. Cell, 41, 354-365.
    [http://www.ncbi.nlm.nih.gov/pubmed/21292167
  4. 徳永文稔、岩井一宏; 新規直鎖状ポリユビキチン鎖生成によるNF-κBシグナル制御 (2011) 実験医学,  29(12), 2001-2006.

2010

  1. Taichi Kumanomidou, Tomomi Nakagawa, Tsunehiro Mizushima, Atsuo Suzoki, Fuminori Tokunaga, Kazuhiro Iwai, Yukiko Yoshida, Keiji Tanaka, and Takashi Yamane; Crystallization and preliminary X-ray characterization of the Skp1-Fbg3 complex. (2010) Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun., 66, 95-98. [http://www.ncbi.nlm.nih.gov/pubmed/20057081
  2. 徳永文稔、岩井一宏; ユビキチン修飾系によるNF-κBシグナル伝達制御:新規直鎖状ポリユビキチン鎖形成を介するNF-κB制御機構の発見 (2010) 細胞工学,  29(12), 1224-1230.
  3. 徳永文稔;ユビキチンープロテアソーム系の多彩な生理機能と疾患への関与 (2010) BIO Clinica 25(12), 1092-1097.

2009

  1. Fuminori Tokunaga, Shin-ichi Sakata, Yasushi Saeki, Yoshinori Satomi, Takayoshi Kirisako, Kiyoko Kamei, Tomoko Nakagawa, Michiko Kato, Shigeo Murata, Shoji Yamaoka, Masahiro Yamamoto, Shizuo Akira, Toshifumi Takao, Keiji Tanaka, Kazuiro Iwai; Involvement of linear polyubiquitylation of NEMO in NF-κB activation. (2009) Nature Cell Biol. 11, 123-132. [http://www.ncbi.nlm.nih.gov/pubmed/19136968
  2. Kazuhiro Iwai and Fuminori Tokunaga; Linear polyubiquitination: a new regulator of NF-κB activation. (2009) EMBO Rep. 10, 706-713.
  3. 岩井一宏、坂田真一、中川朋子、徳永文稔;アレルギーやガンに関わるNF-κBの新しい活性化機構の発見:新規ユビキチン修飾、直鎖状ポリユビキチン化によるNF-κB活性化(2009)化学と生物 47, 602-604.
  4. 徳永文稔、岩井一宏; NEMOの直鎖状ポリユビキチン化修飾によるNF-κB活性化 (2009) 蛋白質核酸酵素 54, 635-642.